Roxane's morphine solution receives FDA approval

01/26/2010 | United Press International · Bloomberg Businessweek

The FDA approved Roxane Laboratories' morphine sulfate oral solution for opioid-tolerant patients with moderate to severe pain. The approval covers the doses of 100 milligrams per 5 milliliters and 20 milligrams per 1 milliliter.

View Full Article in:

United Press International · Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care